Behavioral Intervention Program and Vaginal Cones on SUI

NCT ID: NCT01628991

Last Updated: 2012-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2009-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a single blind randomized clinical trial to compare the efficacy of a behavioral intervention program versus vaginal cones on Stress Urinary Incontinence (SUI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Detailed Description: In this single-blind randomized clinical trial, 60 women aged 25-65 yrs with stress urinary incontinence were randomly divided in two groups by blocked randomization method; behavioral intervention program (n=30) and insertion vaginal device,vaginal cones (n=30). Women in behavioral intervention group were instructed for pelvic floor exercise and bladder control strategies. Other group was allocated to use vaginal cones. They were treated for 12 weeks and followed up every 2 weeks. The subjective changes in severity of SUI were measured using a Detection SUI Severity Questionnaire and leakage index and 3-day urinary dairy. The objective changes were measured by pad test. These two groups were then compared according to the scores of special questionnaires for quality of life, strength of pelvic floor muscles, capability to participate in social activities, severity of urinary incontinence, and the number of involuntary urine passage, taken before, and after 1 and 3 months after finishing interventions. Data analysis will be done through descriptive and perceptive statistical methods by using SPSS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

behavioural intervention

Recieving interventional behavioural program

Group Type EXPERIMENTAL

behavioural program

Intervention Type BEHAVIORAL

interventional behavioural program

vaginal cone

intravaginal device insertion(vaginal cone)

Group Type EXPERIMENTAL

Iranian version of vaginal cones

Intervention Type DEVICE

intravaginal device(vaginal cone) for promote the pelvic floor exercises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

behavioural program

interventional behavioural program

Intervention Type BEHAVIORAL

Iranian version of vaginal cones

intravaginal device(vaginal cone) for promote the pelvic floor exercises

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

bladder training program, exercise therapy intravaginal cones with different weights,Physical Therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* symptoms of SUI , at least three episodes of stress incontinence per week
* Age 25-65
* body mass index (BMI) ≤ 30 kg/m2
* physical health

Exclusion Criteria

* chronic degenerative diseases affected on muscular and nerve tissues
* vulvovaginitis, atrophic vaginitis,
* pregnancy
* active or recurrent urinary tract infections
* advanced genital prolepses
* patients with cardiac pacemakers
Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mashhad University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

nahid golmakani

Faculty member,MSc of Midwifery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nahid golmakani, M.Sc.

Role: STUDY_DIRECTOR

Mashhad university of medical science, faculty of nursing and midwifery, Mashhad, Iran

Nayereh khadem, M.D.

Role: STUDY_CHAIR

Mashhad university of medical science, Mashhad, Iran

Arezoo Arabipoor, M.Sc.

Role: PRINCIPAL_INVESTIGATOR

Mashhad university of science, faculty of nursing and midwifery, Mashhad, Iran

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mashhad university of medical science

Mashhad, , Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

clinical trial

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PFU vs. UDS in SUI
NCT06886997 NOT_YET_RECRUITING
Tele-rehabilitation for Women With Urinary Incontinence
NCT06161324 ENROLLING_BY_INVITATION NA